AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...

Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction of approximately 40% of employees Corporate even ...

Another Missouri basketball game, another Caleb Grill masterclass. Here's how he made his latest case as the nation's top shooter in a win over Mississippi State.

Intensive Training Course on Pre- and Post-Market StudiesDublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Studies: Clinical Evidence Training Course (ONLINE EVENT: April 7-8, 2025)" has ...

This is the 12th independent registry from CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific. It complements an existing CorEvitas registry focused on AA in ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to delaying or preventing Alzheimer's, challenging long-held assumptions about ...

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

Established in 2021, the World Tumor Registry is being developed as a collection of registries or individual cancer sites, each to contain thousands of searchable digital microscopic images of cancer ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...